General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a woman signing a form imageApril 27 2018

NHS England is asking health professionals to sign up to a national pledge to stop overmedication for people with a learning disability, autism or both.

Its renewed drive to widen support for the ‘Stopping Over Medication of People with a Learning Disability (STOMP)’ initiative is targeting NHS trusts, CCGs and those in the independent sector. It asks that health professionals review and seek alternatives to prescribing psychotropic drug prescriptions.

“The STOMP pledges to help make sure psychotropic drugs are only used for the right reason, in the right amount, for as short a time as possible,” said NHS England.

“An estimated 35,000 adults with a learning disability, autism or both are being prescribed an antipsychotic, an antidepressant or both without appropriate clinical justification. Long-term use of these drugs can lead to significant weight gain, organ failure and, in some cases, death.”

STOMP aims to:

  • encourage people to have regular check-ups about their medicines;
  • make sure doctors and other health professionals involve people, families and support staff in decisions about medicines;
  • inform everyone about non-drug therapies and practical ways of supporting people so they are less likely to need as much medicine, if any.

Among the organisations supporting the launch of STOMP in 2016 was the Royal Pharmaceutical Society. Public Health England Learning Disability Observatory published a guide for staff in pharmacy and learning disability support teams in 2017. It is about best practice for supporting people with a learning disability, autism or both.

The Centre for Pharmacy Postgraduate Education has also launched online learning for pharmacists to develop awareness, understanding and key skills to help them deliver high quality care.

Link:
NHS England announcement     
NHS learning disabilities professional resources 
CPPE ‘Learning disabilities’ distance learning     

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...